Heavy/Light-Chain Analysis of Monoclonal Gammopathies
Open Access
- 1 September 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 55 (9), 1606-1608
- https://doi.org/10.1373/clinchem.2009.132753
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ RatiosClinical Chemistry, 2009
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersLeukemia, 2008
- Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain AssaysMayo Clinic Proceedings, 2006
- Serum Free Light Chains: An Alternative to the Urine Bence Jones Proteins Screening Test for Monoclonal GammopathiesClinical Chemistry, 2006
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M ProteinsAmerican Journal of Clinical Pathology, 2005
- Measurement of β1- and β2-Globulins Improves Detection of M-Spikes on High-Resolution ElectrophoresisClinical Chemistry, 2003
- Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myelomaBlood, 2001
- Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantationBone Marrow Transplantation, 2000
- Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell TransplantationBlood, 1998